Business Description
DiagnosTear Technologies Inc
NAICS : 339115
SIC : 3912
Description
DiagnosTear Technologies Inc is an ophthalmic company developing and commercializing disruptive diagnostic solutions for better management of eye diseases. Its TeaRx technology is a diagnostic platform intended for rapid, Point-of-Care Testing (POCT) of ophthalmic pathologies through multi-parameter analysis of non-invasively collected tear fluid. The first CE-IVD and Israeli MoH-approved test based on the TeaRx platform is intended for diagnosis of Dry Eye Syndrome. This product is not FDA-cleared yet. Beyond DES, It is developing innovative tests based on the TeaRx platform for additional ophthalmic indications. Its pipeline includes TeaRx Red Eye; The first test of its kind for differential assessment of adenoviral conjunctivitis, Herpetic Keratitis and Allergic conjunctivitis.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.23 | |||||
| 9-Day RSI | 25.69 | |||||
| 14-Day RSI | 28.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DiagnosTear Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 28.57 | ||
| 14-Day ATR (C$) | 0.0825 | ||
| 20-Day SMA (C$) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.35 - 0.71 | ||
| Shares Outstanding (Mil) | 58.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DiagnosTear Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DiagnosTear Technologies Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
DiagnosTear Technologies Inc Frequently Asked Questions
What is DiagnosTear Technologies Inc(XCNQ:DTR)'s stock price today?
The current price of XCNQ:DTR is C$0.40. The 52 week high of XCNQ:DTR is C$0.71 and 52 week low is C$0.35.
When is next earnings date of DiagnosTear Technologies Inc(XCNQ:DTR)?
The next earnings date of DiagnosTear Technologies Inc(XCNQ:DTR) is .
Does DiagnosTear Technologies Inc(XCNQ:DTR) pay dividends? If so, how much?
DiagnosTear Technologies Inc(XCNQ:DTR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers